Gerresheimer AG Logo

Gerresheimer AG

Global provider of packaging and drug delivery systems for pharma, biotech, and cosmetics.

GXI | F

Overview

Corporate Details

ISIN(s):
DE000A0LD6E6
LEI:
5299006GD4UWSYZOKC28
Country:
Germany
Address:
Klaus-Bungert-Straße 4, 40468 Düsseldorf
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

Gerresheimer AG is a global partner and solutions provider specializing in primary packaging and drug delivery systems for the pharmaceutical, biotech, and cosmetics industries. The company develops and manufactures a broad portfolio of high-quality glass and plastic products, including pharmaceutical vials, syringes, ampoules, cartridges, and containers. It also offers integrated solutions for drug delivery devices, such as inhalers and auto-injectors, acting as a full-service partner from concept development to the finished product. Additionally, Gerresheimer provides packaging for the perfume and personal care sectors and serves as a supplier for diagnostic and medical device components.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-26 09:46
Regulatory News Service
English 13.9 KB
2025-11-20 13:18
Board/Management Information
Gerresheimer AG: Change in the Supervisory Board
English 9.3 KB
2025-11-19 18:38
Declaration of Voting Results & Voting Rights Announcements
English 15.5 KB
2025-11-18 10:02
Environmental & Social Information
Gerresheimer: Science Based Targets Initiative confirms CO2e Reduction Targets
English 13.3 KB
2025-11-17 17:11
Declaration of Voting Results & Voting Rights Announcements
English 13.4 KB
2025-11-12 18:26
Declaration of Voting Results & Voting Rights Announcements
English 15.5 KB
2025-11-10 16:10
Declaration of Voting Results & Voting Rights Announcements
English 16.8 KB
2025-11-06 11:32
Declaration of Voting Results & Voting Rights Announcements
English 14.3 KB
2025-11-03 11:36
Declaration of Voting Results & Voting Rights Announcements
English 16.3 KB
2025-10-31 11:32
Declaration of Voting Results & Voting Rights Announcements
English 19.7 KB
2025-10-30 10:54
Declaration of Voting Results & Voting Rights Announcements
English 19.7 KB
2025-10-29 10:40
Declaration of Voting Results & Voting Rights Announcements
English 16.0 KB
2025-10-28 16:10
Board/Management Information
Gerresheimer: Uwe Rohrhoff takes over as interim CEO for Dietmar Siemssen
English 10.5 KB
2025-10-27 10:05
Declaration of Voting Results & Voting Rights Announcements
English 14.9 KB
2025-10-25 19:24
Legal Proceedings Report
Gerresheimer AG: Initial findings of an external independent investigation into…
English 7.9 KB

Automate Your Workflow. Get a real-time feed of all Gerresheimer AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Gerresheimer AG

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Gerresheimer AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-11-13 Siemssen, Dietmar Board Buy None 74,994.10 EUR
2022-10-14 Siemssen, Dietmar Board Buy None 137,500.00 EUR
2022-10-14 Simon-Schröter, Dr Wolfram Other Buy None 2,958.00 EUR
2022-09-19 Abt, Andrea Supervisory board Buy None 25,075.00 EUR
2022-09-19 Empl, Andreas Board Buy None 1,820.00 EUR
2022-07-18 Siemssen, Dietmar Board Buy None 151,730.25 EUR
2021-07-14 Burkhardt, Dr. Lukas Board Buy None 181,357.60 EUR
2021-07-14 Siemssen, Dietmar Board Buy None 139,732.50 EUR

Peer Companies

Bone Biologics Corp Logo
Developing a protein-based bone graft for targeted bone regeneration in spinal fusion.
United States of America
BBLG
Bonesupport Holding Logo
Develops & markets injectable bioceramic bone grafts that remodel into bone to heal fractures.
Sweden
BONEX
Bonyf N.V. Logo
Develops patented oral, dental, and dermatological care products for consumers and professionals.
Belgium
MLBON
BOSTON SCIENTIFIC CORP Logo
Develops innovative, less-invasive medical devices for various interventional specialties.
United States of America
BSX
Boule Diagnostics Logo
Global provider of complete hematology systems for human and veterinary diagnostics.
Sweden
BOUL
BrainCool AB Logo
Develops medical cooling systems to protect the brain after cardiac arrest, stroke, or injury.
Sweden
BRAIN
CARLSMED, INC. Logo
AI-driven planning and patient-specific 3D-printed implants for spinal fusion surgery.
United States of America
CARL
Carl Zeiss Meditec AG Logo
Develops medical tech for ophthalmology & microsurgery, from diagnostics to surgical systems.
Germany
AFX
CARMAT Logo
Develops an implantable artificial heart as a bridge-to-transplant for heart failure patients.
France
ALCAR
CASTLE BIOSCIENCES INC Logo
Provides genomic tests for dermatologic cancers to guide personalized treatment decisions.
United States of America
CSTL

Talk to a Data Expert

Have a question? We'll get back to you promptly.